openPR Logo
Press release

Artificial Intelligence In Cancer Diagnostics Market Size Forecasted To Achieve $1.55 Billion By 2029 With Steady Growth

05-01-2025 07:49 AM CET | IT, New Media & Software

Press release from: The Business Research Company

Artificial Intelligence In Cancer Diagnostics

Artificial Intelligence In Cancer Diagnostics

The Artificial Intelligence In Cancer Diagnostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Artificial Intelligence In Cancer Diagnostics Market Size and Projected Growth Rate?
The Artificial Intelligence In Cancer Diagnostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Artificial Intelligence In Cancer Diagnostics Market Size and Projected Growth Rate?

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12685

What Are the Major Segments in the Artificial Intelligence In Cancer Diagnostics Market?
The artificial intelligence in cancer diagnostics market covered in this report is segmented -

1) By Component: Software Solutions, Hardware, Services
2) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types
3) By Application: Screening And Diagnosis, Tumor Identification, Surveillance, Treatment
4) By End-User: Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research Organization

Subsegments:
1) By Software Solutions: Imaging Analysis Software, Predictive Analytics Software, Decision Support Systems, Data Management Platforms
2) By Hardware: Imaging Devices, Biomarkers Detection Equipment, Computing Infrastructure
3) By Services: Consulting Services, Implementation Services, Maintenance And Support Services, Training Services

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12685&type=smp

What Are The Driving Artificial Intelligence In Cancer Diagnostics Market Evolution?
The escalating number of cancer cases is predicted to fuel the expansion of the artificial intelligence segment in the market for cancer diagnostics. Cancer, characterized by unchecked cell growth affecting diverse organs, adds significantly to worldwide morbidity and mortality rates. AI is employed in cancer diagnostics to enable precise and rapid analysis of medical imaging data, assisting in the early identification and accurate categorization of cancerous growths. For example, the World Health Organization reported in February 2024 that in 2022, a shocking 20 million new cancer cases were recorded, resulting in 9.7 million fatalities. Approximately 53.5 million people were alive five years after getting a cancer diagnosis. Consequently, the mounting incidence of cancer is likely to drive the growth of artificial intelligence in the cancer diagnostics market.

Which Firms Dominate The Artificial Intelligence In Cancer Diagnostics Market Segments?
Major companies operating in the artificial intelligence in cancer diagnostics market include Microsoft Corporation, Pfizer Inc., Johnson & Johnson's, Siemens, Roche Holding AG, Google LCC, International Business Machines Corporation, Thermo Fisher Scientific Inc., Oracle Corporation, GE Healthcare, Illumina Inc., Bio Rad Laboratories Inc., Flatiron Health, Tempus Labs Inc., Paige AI Inc., OncoHealth Corporation, Path AI Inc., Aidoc, Sophia Genetics SA, Digital Diagnostics Inc., Prognos Health, Aidence, Kheiron Medical Technologies Limited, Zebra Medical Vision, Niramai, Enlitic Inc., Therapixel, Medial EarlySign Ltd., Freenome, SkinVision B.V.

What Trends Are Expected to Dominate the Artificial Intelligence In Cancer Diagnostics Market in the Next 5 Years?
Advancements in technology are emerging as a prominent trend in the artificial intelligence aspect of the cancer diagnostics market. Companies holding significant shares in this market are focused on developing novel instruments designed particularly for diagnosing different types of cancer in order to maintain their market standing. For instance, Qritive, a firm based in Singapore that specializes in AI-enabled solutions to aid pathologists, unveiled a unique AI-based instrument for diagnosing prostate cancer, named QAi Prostate, in March 2023. QAi Prostate is capable of accurately pinpointing regions with prostatic adenocarcinoma and differentiating between benign and malignant tumor areas in biopsy tissue specimens. The instrument offers comprehensive data on the tumor's size and presence percentage in each slide or region of interest (ROI), enabling pathologists to make faster and more accurate decisions.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

Which Is The Largest Region In The Artificial Intelligence In Cancer Diagnostics Market?
North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Artificial Intelligence In Cancer Diagnostics Market?
2. What is the CAGR expected in the Artificial Intelligence In Cancer Diagnostics Market?
3. What Are the Key Innovations Transforming the Artificial Intelligence In Cancer Diagnostics Industry?
4. Which Region Is Leading the Artificial Intelligence In Cancer Diagnostics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Intelligence In Cancer Diagnostics Market Size Forecasted To Achieve $1.55 Billion By 2029 With Steady Growth here

News-ID: 3995668 • Views:

More Releases from The Business Research Company

Ventricular Assist Device Industry Outlook 2025-2029: Market Set to Cross $3.87 Billion Milestone
Ventricular Assist Device Industry Outlook 2025-2029: Market Set to Cross $3.87 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Ventricular Assist Device Market Size By 2025? The market size of the ventricular assist device has seen rapid expansion in recent years. A growth from $2.12 billion in 2024 to $2.37 billion in 2025 is projected, reflecting a compound annual growth rate (CAGR) of 11.8%.
Key Trends Reshaping the Sunglasses Market: Leading Sunglass Brands Embrace AI With Chatgpt-Enabled Smart Eyewear Industry Transformation
Key Trends Reshaping the Sunglasses Market: Leading Sunglass Brands Embrace AI W …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Sunglasses Market Size Growth Forecast: What to Expect by 2025? In recent times, the market size of sunglasses has been on a progressive rise. It is projected to increase from $18.11 billion in 2024 to an estimated $18.93 billion in 2025, experiencing a compound annual growth rate (CAGR) of
Advanced Diagnostics And Treatments Drive Demand For PTA Balloon Catheters: A Key Catalyst Accelerating PTA Balloon Catheter Market Growth in 2025
Advanced Diagnostics And Treatments Drive Demand For PTA Balloon Catheters: A Ke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. PTA Balloon Catheter Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the recent past, the market size for pta balloon catheter has seen substantial growth. The projections reveal that the growth scale will go up from $2.33 billion in 2024 to $2.56 billion in
Soaring Demand Set to Propel Nuclear Medicine Diagnostics Market to $12.38 Billion by 2029
Soaring Demand Set to Propel Nuclear Medicine Diagnostics Market to $12.38 Billi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Nuclear Medicine Diagnostics Market Through 2025? In recent years, the nuclear medicine diagnostics market has seen a quick expansion. The market's size will increase from $7.16 billion in 2024 to $7.88 billion in 2025 at a compound annual growth rate (CAGR) of

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For